Aethlon Medical, Inc. (AEMD)
- Previous Close
0.3945 - Open
0.3830 - Bid --
- Ask --
- Day's Range
0.3800 - 0.3949 - 52 Week Range
0.2400 - 2.3500 - Volume
74,911 - Avg. Volume
777,087 - Market Cap (intraday)
5.381M - Beta (5Y Monthly) 1.75
- PE Ratio (TTM)
-- - EPS (TTM)
-2.7900 - Earnings Date Feb 12, 2025 - Feb 17, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.85
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
www.aethlonmedical.comRecent News: AEMD
View MorePerformance Overview: AEMD
Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AEMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AEMD
View MoreValuation Measures
Market Cap
5.44M
Enterprise Value
-616.84k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.37
Price/Book (mrq)
0.90
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-50.46%
Return on Equity (ttm)
-105.38%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-11.5M
Diluted EPS (ttm)
-2.7900
Balance Sheet and Cash Flow
Total Cash (mrq)
9.07M
Total Debt/Equity (mrq)
9.98%
Levered Free Cash Flow (ttm)
-5.21M